Keywords: Pfizer, Pain Therapeutics, Remoxy, USA, FDA, Opioid analgesic

US FDA again turns down approval of Pfizer and Pain Thera’s Remoxy

Article | 28 June 2011

Print This

Pain Therapeutics (Nasdaq: PTIE) saw its shares plummet last Friday when, along with development partner global drugs behemoth Pfizer (NYSE: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in